|Posted on January 4, 2010 at 5:25 PM|
Hyperbaric oxygen therapy (HBOT) was originally used by placing a patient with the "bends" or nitrogen sickness in a pressure chamber and increasing the pressure to 3.0 atmosphere with 100% oxygen. Not long after, it was recognized that hyperbaric oxygen therapy could also facilitate wound healing in patients with poor circulation.
The first open heart surgeries were performed in a hyperbaric oxygen chamber without the use of heart and lung bypass machines. This is possible because when the body is super saturated with oxygen, all the vital tissues still receive it, so the heart can remain at rest without any detriment to the patient.
Oxygen is a critical substrate in the alleviation of hypoxia, or very low oxygen conditions. Furthermore, the beneficial effects of oxygen have been augmented by administration at doses above normal atmospheric pressure and at higher concentrations. The pressures suitable for cardiovascular disease are typically administered at 1.4 atmosphere of pressure.
While researchers remain mystified at the remarkable effects HBOT has on heart attack, I have long suspected that it works by alleviating the accumulation of acid in the left ventricular tissue. When low oxygen conditions are present (hypoxia) result in tissue acidosis.
When a heart patient has been crippled with cardiac drugs, a series of hyperbaric oxygen therapy treatments can stimulate various growth factors as well as stem cells, which migrate from the bone marrow to facillitate repair of damaged tissue. Moreover, an environment that is super saturated with oxygen can neutralize microbes and drastically reduce inflammation.
As mentioned in some previous Daily Topic issues on heart disease, magnesium in the form of magnesium orotate is very useful for cardiovascular disease, especially those who have had a heart attack or heart surgery.
Because magnesium orotate is not particulary soluble in water, it delivers magnesium directly to the cells without any gastrointenstinal disturbance. Its effects with respect to arterial plaque are a reduction in calcification of damaged heart tissue, increasing HDL cholesterol, and reduction of the monocyte conversion to macrophages in the endothelium, which is how it prevents plaque formation.
Moreover, in animal research, magnesium orotate therapy have been shown to prevent and reduce arteriosclerosis (stiffening of arteries). Additionally reducing calcification of soft tissue.
Recent research points towards the potential of vitamin D to reduce plaque formation in the arteries. When 375 patients with type I diabetes (insulin-dependent) were assessed for their vitamin D levels, it was found that those whose levels were below 25 nmol/L, the risk rose 3 times greater to develop calcified plaque blockages than those who had levels above 75 nmol/L.
This finding may not be so surprising when considering that Vitamin D deficiency was associated with an increased C-Reactive Protein (CRP) level. This measure indicates probable blood vessel lining inflammation.
Some interesting studies, more or less ignored by the mainstream showed significant plaque reduction when both iodide and niacin were used. Iodide dissolves waxes, which is essentially what sticky plaque is made out of. Niacin can increase HDL, lowering triglycerides and reduce Lp(a) levels.
In integrative medicine, a treatment known as Plaque-X is used to remove arterial plaque. Plaque-X is the intravenous use of egg derived Phosphatidylcholine. This treatment was originated Europe, however the patent has long expired so its use in conventional medicine has fallen out of favor.
Fortunately Plaquex is still available, and it's also known as essential phospholipid therapy. I had the opportunity to look through a patent using this therapy and had noticed it also has an application for hair loss.
In the patent, it stated that the invention includes a method of achieving hair regrowth in a person suffering from male pattern baldness. In one section, it stated the following, "An elderly male subject with scalp hair loss was treated with liposomes, the subject noticed a significant improvement in hair regrowth after liposome treatment.This was also followed by a reduction in Lp(a) levels.
That stated however, there is an alternative to intravenous essential phospholipid therapy or Plaque-X. It's not lecithin, which normally one would consider when thinking of phospholipids, because the micelles cannot accept all that much lecithin within the blood stream. Fortunately, there is a product that allows the essential phospholipids to enter into the blood stream.
The product in question is natural essential phospholipids (EPL) that is encapsulated in liposomes, allowing for greater absorption through the gut wall. One such brand is Nutricology's LipoPhos Forte.
I intended to write more about heart disease in the future, however for the time being, I will give a deserving break to explore other pressing subjects.